The World Health Organization released a progress assessment on the Global Health Sector Strategies (GHSS) for HIV, viral hepatitis and sexually transmitted infections spanning 2022–2030, unveiled during the 26th International AIDS Conference (AIDS 2026) in late July 2026. The report documents both significant progress and persistent implementation gaps in the global health response to three interconnected epidemics affecting hundreds of millions of people worldwide.
Key takeaways
- WHO released a progress assessment of its Global Health Sector Strategies on HIV, hepatitis and STIs, acknowledging both achievements and persistent challenges in implementation
- The report emphasises integration across HIV, viral hepatitis and STI programmes as essential to improving health outcomes and reducing fragmentation in service delivery
- Community leadership and innovation in prevention, testing and treatment are identified as core pillars for closing gaps in the global health response by 2030
Strategic pillars of the WHO GHSS response, 2022–2030
Core implementation domains identified for HIV, viral hepatitis and STI elimination
Source: WHO Global Health Sector Strategies assessment, 2026 | Georgian Medical Journal News
Integration as the pathway to closing implementation gaps
The WHO report emphasises that fragmented, disease-specific health programmes have historically hindered progress in combating HIV, viral hepatitis and STIs. According to the WHO assessment released at AIDS 2026, integrating prevention, testing and treatment services across all three conditions offers opportunities to reduce redundancy, improve resource efficiency and strengthen primary healthcare systems overall.
Integrated service delivery models allow healthcare providers to reach shared vulnerable populations—including key populations such as people who inject drugs, sex workers and men who have sex with men—through unified platforms rather than parallel, isolated programmes. This approach aligns with the WHO’s vision of integrated sexual and reproductive health services, which treats HIV, hepatitis B and C, and STIs as interconnected health challenges requiring coordinated responses.
Community leadership as a driver of sustainability
The report highlights that sustained epidemic control depends on meaningful engagement of affected communities and civil society organisations. Communities directly impacted by HIV, viral hepatitis and STIs possess knowledge of local barriers to care, trusted communication channels and cultural competency that health systems often lack. According to the WHO assessment, programmes that centre community voice in strategy design, implementation and monitoring achieve higher coverage and sustainability than top-down, biomedically driven approaches.
This principle extends to peer-led prevention, testing and treatment support models, which have demonstrated effectiveness in reaching marginalised populations. Health equity remains central to achieving the 2030 targets, and community partnerships are identified as non-negotiable foundations for this work.
Innovation in diagnostics and prevention as critical accelerators
The WHO report identifies technological and programmatic innovation as essential to accelerating progress toward 2030 elimination targets. According to the WHO assessment, advances in rapid diagnostics, self-testing platforms and digital tools for case tracking have expanded access to services in resource-limited settings. Innovation in prevention—including long-acting injectable antiretrovirals, pre-exposure prophylaxis (PrEP) delivery models and simplified hepatitis C treatment regimens—offer pathways to reach populations previously underserved by conventional health infrastructure.
The integration of digital health tools, artificial intelligence-powered epidemiological tracking and decentralised testing also enhances the ability of national health systems to identify gaps and target resources effectively. Recent advances in treatment accessibility demonstrate that innovation alone must be paired with equitable implementation strategies to realise public health gains.
Integration across HIV, viral hepatitis and STI programmes, coupled with community leadership and innovation in prevention and diagnostics, represents the pathway to closing persistent gaps in the global health response and achieving 2030 elimination targets.
— World Health Organization, Global Health Sector Strategies Progress Assessment, 2026
What this means
Frequently asked questions
Why does WHO emphasise integration of HIV, hepatitis and STI programmes rather than separate responses?
These three epidemics share common transmission routes, affect overlapping populations and require similar prevention and treatment approaches. Integrated programmes reduce redundancy, improve resource efficiency and strengthen health systems. The WHO’s integrated approach reflects evidence that unified strategies outperform fragmented disease-specific silos in reaching marginalised and vulnerable populations.
What role do communities play in the new GHSS framework?
According to the WHO report, community organisations and people with lived experience serve as co-designers and implementers of programmes, not passive beneficiaries. Community leadership improves cultural acceptability, increases coverage among key populations and ensures programmes are responsive to local needs. This participatory approach has been central to AIDS response success and extends to hepatitis and STI elimination efforts.
How does innovation in diagnostics and prevention support the 2030 targets?
Rapid point-of-care testing, self-testing platforms and long-acting prevention methods (such as PrEP and injectable antiretrovirals) dramatically expand access beyond clinical settings into communities, reducing barriers to diagnosis and treatment initiation. The WHO report identifies these innovations as force multipliers that enable resource-limited settings to achieve high coverage and accelerate epidemic control by 2030.
As countries prepare for the next phase of implementation planning, the WHO assessment serves as a roadmap for aligning national HIV, hepatitis and STI strategies with the 2022–2030 GHSS framework. Success will depend on sustained political commitment, equitable funding, meaningful community partnership and health system strengthening that positions integration, innovation and equity as non-negotiable priorities in the global response.
Source: WHO: Integration, innovation and community leadership key to ending HIV, hepatitis and STIs
Was this article helpful?
Related Coverage
